EIF2AK2 and hepatocellular carcinoma: LINC00265 has been shown to predict undesirable findings in cases with AML [30], while LINC00665 has been associated with enhanced activation of the pathway of PKR/NF-κB hepatocellular carcinoma and with concomitant increases in malignancy [31], while in gastric cancer, this same lncRNA can activate the Wnt pathway to promote tumor progression [32].